Figure 5.
The GBM cell viability and migration were inhibited by NP/siRNA complexes. (A) The cell viabilities of U-87 and U-251 cells treated with NP/siRNA targeting REST for 24 h were analyzed by CCK-8 assay; (B) The cell viabilities of U-87 and U-251 cells treated with NP/siRNA targeting REST for 48 h were analyzed by CCK-8 assay; (C,D) The cell migration capacities of U-87 and U-251 cells treated with NP/siRNA targeting REST, analyzed using transwell assay. Bar indicates 100 μm. * p < 0.05 compared with the control group.